Adriana María Belén Abiuso et al.
The Journal of endocrinology, 223(3), 241-253 (2014-09-26)
The histamine H4 receptor (HRH4), discovered only 13 years ago, is considered a promising drug target for allergy, inflammation, autoimmune disorders and cancer, as reflected by a steadily growing number of scientific publications and patent applications. Although the presence of